Oncotype DX Testing
NHS Greater Glasgow and Clyde are seeking an organisation to provide Oncotype DX Testing. The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient’s tumour in order to optimise cancer treatment decisions by providing answers to key questions about the aggressiveness of and appropriate treatment for early stage cancer. The test provides a quantitative assessment of the likelihood of chemotherapy benefit and distant recurrence.
Buyer
NHS Greater Glasgow and Clyde
Value
£875,000
Published
13 May 2019
Closes
13 May 2019
Procurement details
Source
Pcs
Region
UKM82
Procurement method
Not provided
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
85121200
Medical specialist services
Lots
Lot 1 Oncotype DX Testing
Value not provided
NHS Greater Glasgow and Clyde are seeking an organisation to provide Oncotype DX Testing. The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient’s tumour in order to optimise cancer treatment decisions by providing answers to key questions about the aggressiveness of and appropriate treatme...
Delivery: UKM82, UKM81, UKM83
Documents
Unlock document linkOncotype DX Testing
Not provided
NHS Greater Glasgow and Clyde are seeking an organisation to provide Oncotype DX Testing. The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient’s tumour in order to optim...
Planned procurement notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.